FloridaMarijuana.net

JULY 8, 2018

The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The psychological symptoms that develop because of the trauma affect mood, cognition, memories (both suppression and the inability to form new memories) and physical health.

Strains 190

Strains Indica Hybrid Research and Development 190

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

MARCH 17, 2021

Fortunately, a group of trailblazers has found a way to impede (delay or prevent) cell growth in Glioblastoma patients. The team found that a cannabinoid known as CBG is the key to impeding the growth of glioblastoma cells, in turn extending life expectancy and reducing the effects of the condition. . What is CBG?

Research and Development 111

Research and Development Treatment Cannabinoids THC 111

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 179

CBD Blood Pressure Research and Development Cannabinoids 179

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. Let’s go over the three main components of ECS to better understand, they are: endocannabinoids, cannabinoid receptors, and enzymes.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

LifeCannMD

FEBRUARY 1, 2024

Cannabinoids and other compounds found in marijuana have been studied for their potential effects on glaucoma, a group of painful eye conditions that can lead to blindness. The primary reason most glaucoma patients seek medical marijuana treatment is because of lower intraocular pressure (IOP). IOP is extremely painful.

Cannabinoids 98

Cannabinoids Treatment Research and Development THC 98

FloridaMarijuana.net

AUGUST 15, 2018

If this mechanism is forced to be used repeatedly and often, the body does not properly heal or develop. Often, Post-Traumatic Stress Disorder, a debilitating and chronic illness, can develop. Living with PTSD, no matter the underlying cause of the trauma, can be extremely difficult for patients and their loved ones.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Veriheal

SEPTEMBER 18, 2020

Research Team to Study the Impact of CBD on Spinal Injury Pain. million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury. Dr. Carins is a postdoctoral researcher who completed her Ph.D. Along with the $1.7

Treatment 98

Treatment Chronic Pain CBD Research and Development 98

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

CannaMD

NOVEMBER 4, 2020

According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. Other Research Findings.

Patients 105

Patients Chronic Pain Marijuana Research and Development 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. What makes a good research study, anyway?

Research and Development 108

Research and Development Data THC Clinical Trials 108

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Veriheal

SEPTEMBER 30, 2021

Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Additionally, the increase in the availability of cannabis research has led to a decrease in stigmatization attached to cannabis.

Patients 98

Patients Research and Development Treatment Consumption 98

Veriheal

MAY 18, 2023

annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. How Were the New Guidelines for Cannabis in Chronic Pain Developed?

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Project CBD

SEPTEMBER 12, 2023

Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. When scientists blocked the CB1 cannabinoid receptor, ketamine did not prevent pain. There’s a lot going on behind the glamor.

Chronic Pain 233

Chronic Pain Treatment Cannabinoids Research and Development 233

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 111

Consumption Patients Research and Development Data 111

Greencamp

AUGUST 25, 2018

Hence, lupus patients often look for complementary treatments for controlling their symptoms. It makes sense: The most common symptoms that patients with lupus have to deal with are inflammation and pain, and cannabis is known for being especially effective at fighting both. Approximately one in every 1000 Canadians has lupus and 1.5

Cannabinoids 92

Cannabinoids Strains Research and Development Sativa 92

Cannabis Law Report

AUGUST 13, 2021

Instead, it is hypothesised that SalA indirectly influences the cannabinoid system, as well as being an allosteric modulator of the µ opioid receptor. Karl Hanes reported on 7 patients with TRD who described relief from depressive symptoms with continued oral consumption of salvia leaves three times a week. BERLIN, Aug.

Conditions 105

Conditions Research and Development Clinical Trials Treatment 105

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Both upper and lower motor neurons suffer severe damage in ALS patients. Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Veriheal

NOVEMBER 13, 2020

Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Many patients with OCD tend to perform actions without wanting to, but feeling powerless to try and stop it. What Does Research Say About Cannabis and OCD?

Research and Development 98

Research and Development Consumption Patients Strains 98

FloridaMarijuana.net

SEPTEMBER 24, 2018

These essential oils are called Terpenes, and while research is still evolving, science has proven that these oils can drastically improve a patient’s quality of life. The European Journal of Pharmacology stated that this effect “ may represent a novel route for molecular regulation of endogenous cannabinoid activity.”

Terpenes 162

Terpenes Oil Strains Research and Development 162

Veriheal

AUGUST 16, 2021

The National Football League has taken proactive steps moving forward into the future with a research grant to explore potential therapeutic attributes of CBD, cannabis, and other options to treat pain other than opioids. NFL Research Grant Will Invest in a Bright Future for Athletes and Others. The opioid epidemic is real.

Therapy 105

Therapy Chronic Pain Research and Development Treatment 105

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 81

Medicine Research and Development Agriculture Compliance 81

United Patients Group

SEPTEMBER 7, 2023

As the perception of medical marijuana evolves and an increasing number of individuals explore its therapeutic potential, it’s crucial to develop a comprehensive understanding of cannabis’ impact on bodily systems. One area of interest and ongoing research is the relationship between cannabis and the immune system.

Research and Development 111

Research and Development Conditions Cannabinoids Patients 111

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Veriheal

MAY 2, 2023

5, 1930, “the father of cannabis research” was born. From the Black Sea-encapsulated mountainous terrain of Bulgaria, Professor Raphael Mechoulam immigrated to Israel, where he would make a legendary name for himself as a pioneer in medical cannabis research. Had it not been for Prof.

Research and Development 98

Research and Development Epilepsy Cannabinoids Medicine 98

Veriheal

MAY 9, 2022

New cannabis research found that a cannabis-based drug was able to kill pancreatic cancer cells. However, much like cannabis, they concluded that information on these mushrooms is still unclear and that further research and investigation are needed. Cyathus and Cannabinoids: The Cancer-Cell-Killing Duo.

Research and Development 23

Research and Development Extraction Treatment Cannabinoids 23

CannaMD

MARCH 8, 2020

In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. Researchers summarized five key points from the 2020 review : * We estimate that more than 2 million U.S. Marijuana Heart Study Summary. Oxidative stress and peripheral artery disease.

Patients 104

Patients Marijuana Research and Development Clinical Trials 104

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. So, why did this educational gap develop? Unfortunately, this did not occur.

Patients 98

Patients Education Marijuana Therapy 98

LifeCannMD

MARCH 3, 2025

In Miami, Dr. Fernando Fandio-Sende researches innovative approaches to OCD treatment that have emerged, with medical marijuana integrative wellness strategies increasingly recognized as a potential therapeutic avenue worth exploring. For people dealing with OCD, this connection could be really important.

Research and Development 52

Research and Development Treatment Conditions Patients 52

The Cannigma

MAY 5, 2021

An unknown number of recovered COVID-19 patients are walking through a fog, uncertain when it will end and what can be done to help. While the research doesn’t provide any clear answers, here is what we do know. And to make things worse, most of these people were already told that they were “healed.”. What is long COVID?

Chronic Pain 144

Chronic Pain Research and Development Patients Treatment 144

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. BRC) told The Cannigma this week.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

The Cannigma

OCTOBER 27, 2021

These findings were unearthed in a study titled “Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys,” carried out at the Mason Research Institute in Worcester Massachusetts in 1973. The monkeys were given caring doses of isolated cannabinoids ranging 131.3-3150

THC 144

THC Research and Development Clinical Trials Cannabinoids 144

United Patients Group

SEPTEMBER 14, 2023

Medical cannabis has garnered tremendous attention and acceptance in recent years, with a growing body of research exploring its potential therapeutic benefits for a range of health conditions. Preliminary research also suggests it may have neuroprotective properties. To accomplish this, patients should: 1.

Terpenes 105

Terpenes Research and Development Strains Cannabinoids 105

Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership. This study represents a refreshing collaboration of scientists, clinicians, patients and advocates.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

JUNE 17, 2021

goodblend™ Texas , a retail brand of Parallel , one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabinol (CBN) products for patients registered in the Texas Compassionate Use Program. goodblend™ Texas, a retail brand of Parallel.

Patients 97

Patients Programs Sleep Retail 97